All data are based on the daily closing price as of October 7, 2026
c
Center Laboratories
4123.TWO
0.98 USD
0.01
+1.03%
Overview
Last close
0.98 usd
Market cap
730.62M usd
52 week high
1.56 usd
52 week low
0.94 usd
Target price
N/A usd
Valuation
P/E
84.0541
Forward P/E
2500
Price/Sales
14.0513
Price/Book Value
1.3743
Enterprise Value
748.05M usd
EV/Revenue
14.3862
EV/EBITDA
11.9711
Key financials
Revenue TTM
52.00M usd
Gross Profit TTM
22.50M usd
EBITDA TTM
6.99M usd
Earnings per Share
0.01 usd
Dividend
0.05 usd
Total assets
753.82M usd
Net debt
23.28M usd
About
Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also provides central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei, Taiwan.